|
|
3300 Hyland Drive
Costa Mesa, CA 92626 USA
phone:714.545.0100
fax:714.556.0131
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.xcelpharmaceuticals.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Pharmaceutical products, primarily in the areas of neurology, dermatology and infectious disease. |
|
| Management |
| Robert W. O'Leary; Chairman of the Board, Valeant, Pharmaceuticals International; Lawrence N. Kugelman, Director, Coventry Healthcare; Edward A. Burkhardt President and Chief, Executive Officer, Rail World, Inc. |
| |
|
|
| |
|
| Keywords |
| neurology, dermatology, infectious, disease, scar, tissue, solar, keratoses, psoriasis, infant, respiratorial, infection |
|
|
|
| Description |
|
Valeant Pharmaceuticals International discovers, develops, manufactures and markets pharmaceutical products, primarily in the areas of neurology, dermatology and infectious disease. Valeant's prducts treat scar tissue, solar keratoses, psoriasis, infant respiratorial infection, and neuralogical disorders. |
|
| Products / Services |
Valeant's products are in three areas:
Dermatology: Dermatix, Efudex/Efudix, Kinerase, Oxsoralen-Ultra
Infectious Disease: Virazole, Pradefovir (In Development), Viramidine (In Development)
Neurology: Mestinon, Tasmar, Retigabine (In Development)
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members